PPTLBA-02 BLUE LIGHT FLEXIBLE CYSTOSCOPY (BLFC) WITH HEXAMINOLEVULINATE (HAL) AND WHITE LIGHT FLEXIBLE CYSTOSCOPY: A PROSPECTIVE, COMPARATIVE, WITHIN-PATIENT CONTROLLED MULTI-CENTER PHASE 3 STUDY IN THE DETECTION OF BLADDER CANCER DURING SURVEILLANCE
Siamak Daneshmand(Unknown), Stephen Jones, Joel DeCastro(Columbia University Irving Medical Center), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Yair Lotan(Southwestern Medical Center), Michael J. O’Donnell(University of Iowa), Kamal S. Pohar(The Ohio State University), Gary D. Steinberg(Rush University Medical Center), William C. Huang(NYU Langone Health), Badrinath R. Konety(Allina Health), Michael Woods(University of Cambridge), Sanjay Patel(Oklahoma City University), Trinity J. Bivalacqua(University of Pennsylvania), Jennifer M. Taylor(Michael E. DeBakey VA Medical Center), Mark Schoenberg(Montefiore Medical Center), Edouard J. Trabulsi(Thomas Jefferson University), Matthew J. Resnick(Vanderbilt University Medical Center), Tracy M. Downs(University of Wisconsin–Madison)
Cited by 2
Related Papers
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
|Nature|2021|603